Financials in USD. Standardized financial statements.
A compact view of how Evolent Health, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.88B | $2.55B | $1.96B | $1.35B | $907.96M | $924.64M | $687.12M | $627.06M | $434.95M | $254.19M |
| Revenue Growth? | -26.6% | +30.1% | +45.3% | +48.9% | -1.8% | +34.6% | +9.6% | +44.2% | +71.1% | 0.0% |
| Cost of Revenue? | $1.59B | $2.19B | $1.50B | $1.04B | $657.55M | $696.58M | $513.03M | $327.82M | $269.35M | $155.18M |
| Gross Profit? | $284.03M | $367.35M | $460.47M | $316.58M | $250.41M | $228.06M | $174.09M | $299.24M | $165.60M | $99.01M |
| Gross Margin? | +15.1% | +14.4% | +23.4% | +23.4% | +27.6% | +24.7% | +25.3% | +47.7% | +38.1% | +39.0% |
| Operating Expenses? | $288.47M | $407.84M | $531.68M | $312.94M | $292.82M | $490.90M | $482.97M | $350.82M | $238.04M | $177.92M |
| Operating Income? | -$4.43M | -$40.48M | -$71.21M | $3.64M | -$42.41M | -$262.85M | -$308.88M | -$47.48M | -$72.84M | -$237.42M |
| EBITDA? | $111.42M | $84.85M | -$24.79M | $43.75M | $55.66M | -$240.74M | -$254.52M | -$4.15M | -$40.40M | -$220.31M |
| Income Before Tax | -$534.64M | -$63.04M | -$202.41M | -$62.08M | -$29.80M | -$330.54M | -$329.99M | -$54.15M | -$76.40M | -$237.53M |
| Income Tax Expense | -$126,000 | -$1.41M | -$89.36M | -$43.38M | $483,000 | -$2.37M | -$22.80M | $40,000 | -$6.64M | -$10.76M |
| Net Income? | -$534.51M | -$61.62M | -$113.04M | -$19.16M | -$37.60M | -$334.25M | -$301.97M | -$52.66M | -$60.66M | -$159.74M |
| EPS? | $-5.07 | $-0.81 | $-1.28 | $-0.20 | $-0.36 | $-3.94 | $-3.71 | $-0.68 | $-0.94 | $-3.55 |
| Diluted EPS? | $-5.07 | $-0.81 | $-1.28 | $-0.20 | $-0.36 | $-3.94 | $-3.71 | $-0.68 | $-0.94 | $-3.55 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality